Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avacopan With Short-term Reduced-dose Glucocorticoids vs Reduced-dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-associated Vasculitis

NCT06611696 is registered in ClinicalTrials.gov with Chiba University as lead sponsor.

NCT NCT06611696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avacopan With Short-term Reduced-dose Glucocorticoids vs Reduced-dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-associated Vasculitis
Lead sponsor
Chiba University
Phase
Phase 4
Overall status
Recruiting
Start date
November 15, 2024
Completion date
September 30, 2028
Enrollment
160 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis (aav)